Plasma Galectin-3 and urine proteomics predict FEV1 improvement in omalizumab-treated patients with severe allergic asthma: Results from the PROXIMA sub-studyA Riccio, Giorgio Walter Canonica, Dario Di Silvestre et al.|World Allergy Organization Journal|2020Cited by 23
Proteomics analysis of asthma biomarkers: proxima sub-studyPierluigi Mauri, Giorgio Walter Canonica, A Riccio et al.|Unknown|2017Cited by 1